Decreased Jumonji Domain-Containing 3 at the Promoter Downregulates Hematopoietic Progenitor Kinase 1 Expression and Cytoactivity of T Follicular Helper Cells from Systemic Lupus Erythematosus Patients

Table 1

Profiles of SLE patients.

Patient	Gender	Age (years)	Disease duration (months)	SLEDAI	Medications
1	Female	25	8	6	Pred 35 mg/d, MMF 1.5 g/d
2	Female	26	4	4	Pred 30 mg/d
3	Female	25	5	10	Pred 40 mg/d, CsA 150 mg/d, TG 30 mg/d
4	Female	30	3	8	None
5	Female	34	6	8	Pred 40 mg/d, HCQ 0.2 g/d
6	Male	32	25	4	HCQ 0.2 g/d
7	Female	36	23	6	Pred 30 mg/d, HCQ 0.2 g/d
8	Female	27	7	10	Pred 40 mg/d, MMF 1.5 g/d
9	Female	25	32	16	Pred 40 mg/d, HCQ 0.2 g/d
10	Female	22	6	20	Pred 50 mg/d, MMF 1.5 g/d, HCQ 0.2 g/d
11	Female	20	4	2	None
12	Female	21	8	0	Pred 15 mg/d
13	Female	28	10	2	Pred 10 mg/d, TG 30 mg/d
14	Female	33	13	1	Pred 20 mg/d
15	Female	32	11	6	Pred 25 mg/d, CsA 150 mg/d
16	Female	41	9	8	None
17	Male	40	3	6	Pred 40 mg/d, HCQ 0.2 g/d
18	Female	32	8	6	Pred 30 mg/d, CsA 150 mg/d
19	Female	35	21	0	Pred 5 mg/d
20	Female	24	14	6	None
21	Female	26	6	8	Pred 40 mg/d, MMF 1.5 g/d
22	Male	32	9	6	None
23	Female	35	7	2	TG 30 mg/d
24	Female	22	15	0	Pred 10 mg/d, HCQ 0.2 g/d
25	Female	33	10	7	Pred 35 mg/d
26	Female	35	4	8	Pred 35 mg/d, HCQ 0.2 g/d
27	Female	27	21	8	Pred 35 mg/d, MMF 1.5 g/d
28	Female	25	2	4	None
29	Female	22	9	2	Pred 15 mg/d, HCQ 0.2 g/d
30	Female	23	6	16	Pred 40 mg/d, CsA 150 mg/d, HCQ 0.2 g/d

Abbreviations: SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; Pred: prednisone; MMF: mycophenolate mofetil; CsA: cyclosporin A; TG: tripterygium glycoside; HCQ: hydroxychloroquine.